More Stories

Informist, Wednesday, Aug. 12, 2026

 

Please click here to read all liners published on this story

--Apollo Hospitals Apr-Jun consol net profit INR 5.81 bln 
--Analysts saw Apollo Hospitals Apr-Jun consol net profit at INR 5.58 bln
--Apollo Hospitals Apr-Jun consol revenue INR 70.44 bln
--Analysts saw Apollo Hospitals Apr-Jun consol revenue at INR 68.94 bln
--Apollo Hospitals Apr-Jun consol PAT INR 5.81 bln vs INR 4.33 bln yr ago
--Apollo Hosp Apr-Jun consol revenue INR 70.44 bln vs INR 58.42 bln yr ago
--Apollo Hosp Q1 consol health svcs sales INR 36.20 bln vs INR 29.74 bln
--Apollo Hosp Q1 consol digital health, pharmacy sales INR 29.77 bln
--Apollo Hosp Q1 consol digital health, pharmacy sales up 20.4% on year
--Apollo Hosp Q1 consol retail health, diagnostics revenue INR 5 bln
--Apollo Hosp Q1 consol retail health, diagnostics sales up 14.8% on year
--Apollo Hospitals Q1 consol EBITDA INR 10.92 bln vs INR 8.52 bln year ago
--Apollo Hosp Q1 health services EBITDA INR 8.62 bln vs INR 7.18 bln yr ago
--Apollo Hosp arm HealthCo Q1 revenue INR 29.77 bln vs INR 24.72 bln yr ago
--Apollo Hosp arm HealthCo Q1 EBITDA INR 1.71 bln vs INR 940 mln yr ago
--Apollo Hospitals Apr-Jun hospitals ops occupancy rate 70% vs 65% yr ago 
--Apollo Hospitals operating beds at 8,352 on Jun 30 
--Apollo Hospitals: Plan to add over 5,800 beds over next 5 years 

 

By Narayana Krishna

 

HYDERABAD – Healthy growth in the hospitals business, along with the pharmacy and diagnostics segments, boosted Apollo Hospitals Enterprise Ltd.'s earnings in the June quarter.

The Chennai-headquartered healthcare services company Wednesday reported a consolidated net profit of INR 5.81 billion, up over 34% on year. This was also higher than the Street's expectation of INR 5.58 billion. The company's revenue grew nearly 21% on year to INR 70.44 billion, well above analysts' consensus estimate of INR 68.94 billion. The revenue growth is the highest in 13 quarters. Sequentially, the company's net profit was up nearly 10% and the revenue was up 6.6%.

Apollo Hospitals reported a year-on-year growth of nearly 22% in its healthcare services business, which is the hospitals segment, to INR 36.20 billion.

 

Improved occupancy and traction in new hospitals helped the company to report healthy numbers for the quarter under review. Robust volume growth in specialties and high complex clinical works also boosted the revenues from the hospitals business, the company said in a press release. The company also witnessed 26% year-on-year growth in its revenue from international patients. For the June quarter, Apollo Hospitals reported occupancy at 70% against 65% a year ago.

 

Apollo Hospitals runs a network of hospitals across regions with an operating bed capacity of 8,352 as on Jun. 30. It plans to add 5,800 new beds in the next five years as part of its expansion drive, Apollo Hospitals said in a press release.

The company's subsidiary Apollo HealthCo Ltd., which holds pharmacy and digital health platform Apollo 24/7, registered 20.4% year-on-year growth in its June quarter revenue at INR 29.77 billion. The diagnostics and retail health services arm Apollo Health & Lifestyle Ltd. reported 14.8% year-on-year growth in revenues at INR 5 billion.

 
The company's June quarter earnings before interest, tax, depreciation, and amortisation were at INR 10.92 billion against INR 8.52 billion in the year-ago quarter. Analysts had expected the company's EBITDA to be INR 10.4 billion. While the hospitals business EBITDA was INR 8.62 billion against INR 7.18 billion a year ago, the Apollo HealthCo EBITDA was at INR 1.71 billion against INR 940 million.

The total expenses of Apollo Hospitals for the June quarter were up nearly 19% on year at INR 63.1 billion. The other expenses were up almost 27% at INR 15.6 billion. The employee benefits expense for the quarter increased almost 12% on year to nearly INR 8 billion. Finance cost for the quarter was up 11% at INR 1.2 billion. Tax expenses for the quarter rose nearly 33% to INR 1.9 billion.

Wednesday, Apollo Hospitals shares ended at INR 8,597 on the National Stock Exchange, down 1.8% from Tuesday.  End

 

Edited by Rajeev Pai

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000 

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.